Patents by Inventor Thomas B. Gold

Thomas B. Gold has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE
    Publication number: 20240050376
    Abstract: The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.
    Type: Application
    Filed: October 17, 2023
    Publication date: February 15, 2024
    Applicant: Acorda Therapeutics, Inc.
    Inventors: Joseph E. Cobb, JR., Thomas B. Gold, Rohini D'Souza, Susan L. Way
  • SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE
    Publication number: 20220323362
    Abstract: The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.
    Type: Application
    Filed: November 19, 2021
    Publication date: October 13, 2022
    Applicant: Acorda Therapeutics, Inc.
    Inventors: Joseph E. Cobb, JR., Thomas B. Gold, Rohini D'Souza, Susan L. Way
  • SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE
    Publication number: 20210338590
    Abstract: The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.
    Type: Application
    Filed: July 13, 2021
    Publication date: November 4, 2021
    Applicant: Acorda Therapeutics, Inc.
    Inventors: Joseph E. Cobb, JR., Thomas B. Gold, Rohini D'Souza, Susan L. Way
  • SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE
    Publication number: 20210085614
    Abstract: The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.
    Type: Application
    Filed: December 4, 2020
    Publication date: March 25, 2021
    Applicant: Acorda Therapeutics, Inc.
    Inventors: Joseph E. Cobb, Jr., Thomas B. Gold, Rohini D'Souza, Susan L. Way
  • SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE
    Publication number: 20200253880
    Abstract: The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.
    Type: Application
    Filed: March 23, 2020
    Publication date: August 13, 2020
    Applicant: Acorda Therapeutics, Inc.
    Inventors: Joseph E. Cobb, JR., Thomas B. Gold, Rohini D'Souza, Susan L. Way
  • SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE
    Publication number: 20200108016
    Abstract: The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.
    Type: Application
    Filed: April 6, 2017
    Publication date: April 9, 2020
    Applicant: Acorda Therapeutics, Inc.
    Inventors: Joseph E. Cobb, JR., Thomas B. Gold, Rohini D'Souza, Susan L. Way
  • SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE
    Publication number: 20180344649
    Abstract: The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.
    Type: Application
    Filed: September 28, 2016
    Publication date: December 6, 2018
    Inventors: Joseph E. Cobb, Jr., Thomas B. Gold, Rohini D'Souza, Susan L. Way
  • Coated tablet with zero-order or near zero-order release kinetics
    Patent number: 8858993
    Abstract: Tablets for the controlled release of an active ingredient in a zero-order or near zero-order fashion are provided. The tablet includes a core and a coating. The core includes at least one active pharmaceutical agent and a polyethylene oxide with a molecular weight of between about 1,000,000 and 10,000,000, preferably between about 4,000,000 and 8,000,000. The core material is optionally, but preferably, coated with a cellulosic material. The active pharmaceutical agent can be hydrophilic, hydrophobic, or amphiphilic. When the active pharmaceutical agent is a hydrophilic agent, it is preferred that the coating is a relatively hydrophobic cellulose, such as ethylcellulose or propylcellulose. However, if the tablet is uncoated, it can provide a near-zero-order release rate rather than a zero-order release rate.
    Type: Grant
    Filed: July 18, 2006
    Date of Patent: October 14, 2014
    Assignee: Metrics, Inc.
    Inventors: Thomas B. Gold, Patrick Brian Woodall